ACT Genomics' Series B Round

ACT Genomics raised a round of funding on May 05, 2016.

ACT Genomics (行動基因) is an integrated cancer molecular information company in Taiwan offering genetic profiling services to cancer research, clinical cancer treatment and drug discovery. ACT Ge…

Articles about ACT Genomics' Series B Round: